These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 2341047)

  • 1. A treatment planning program for radioimmunotherapy.
    Macey DJ; DeNardo GL; DeNardo SJ
    Front Radiat Ther Oncol; 1990; 24():123-31; discussion 161-5. PubMed ID: 2341047
    [No Abstract]   [Full Text] [Related]  

  • 2. Radiation treatment of B cell malignancies with immunoconjugate.
    DeNardo GL; DeNardo SJ; O'Grady LF; Mills SL; Lewis JP; Macey DJ
    Front Radiat Ther Oncol; 1990; 24():194-201; discussion 202-3. PubMed ID: 2341050
    [No Abstract]   [Full Text] [Related]  

  • 3. Dosimetry and treatment planning in radioimmunotherapy.
    Leichner PK; Yang NC; Wessels BW; Hawkins WG; Order SE; Klein JL
    Front Radiat Ther Oncol; 1990; 24():109-20; discussion 121-2. PubMed ID: 2160407
    [No Abstract]   [Full Text] [Related]  

  • 4. High dose radioimmunotherapy in malignant lymphoma.
    Eary JF; Press OW
    Recent Results Cancer Res; 1996; 141():177-82. PubMed ID: 8722427
    [No Abstract]   [Full Text] [Related]  

  • 5. High-dose radioimmunotherapy of B cell lymphomas.
    Press OW; Eary JF; Badger CC; Martin PJ; Appelbaum FR; Nelp WB; Krohn KA; Fisher D; Porter B; Thomas ED
    Front Radiat Ther Oncol; 1990; 24():204-13; discussion 225-7. PubMed ID: 2187758
    [No Abstract]   [Full Text] [Related]  

  • 6. A computer program for I-125 seed implant.
    Heikkonen J; Toivola H; Forss M
    Strahlenther Onkol; 1987 Jan; 163(1):29-31. PubMed ID: 3810474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct dose confirmation of quantitative autoradiography with micro-TLD measurements for radioimmunotherapy.
    Griffith MH; Yorke ED; Wessels BW; DeNardo GL; Neacy WP
    J Nucl Med; 1988 Nov; 29(11):1795-809. PubMed ID: 3263479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of the method of ultrasound topometry of the thyroid gland and computer programs in the planning of radioactive iodine therapy].
    Ivanov VN; Parshin VS; Ivanova LF; Denisenko ON; Drozdovskiĭ BIa
    Med Radiol (Mosk); 1990 Apr; 35(4):20-4. PubMed ID: 2186249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiolabeled antibody combined with external radiotherapy for the treatment of head and neck cancer: reconstruction of a theoretical phantom of the larynx for radiation dose calculation to local tissues.
    Maraveyas A; Myers M; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1020-7. PubMed ID: 7866985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Brachytherapy of ocular melanoma: physical and dosimetric aspects of 125I plaques].
    Bard JJ
    Bull Cancer Radiother; 1995; 82(3):295-305. PubMed ID: 8554879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Claimed association of absolute lymphocyte count with therapeutic efficacy of radio-immunotherapy in patients with indolent lymphoma cannot be verified in an independent data set.
    Bishton MJ; Hicks RJ; Prince HM; Ritchie DS; Wolf M; Seymour JF
    Leukemia; 2008 Dec; 22(12):2259-60; author reply 2260-1. PubMed ID: 18480835
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Dosimetric consequences of increased seed strength for I-125 prostate implants. Radiother Oncol. 2003 Sep;68(3):295-7.
    Lee WR
    Radiother Oncol; 2004 Feb; 70(2):209-10; author reply 210. PubMed ID: 15028411
    [No Abstract]   [Full Text] [Related]  

  • 13. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ; Levy R; Miller RA; Uhland W; Schiele J; Ruehl W; Finston R; Day-Lollini P; Goris ML
    Cancer Res; 1990 Aug; 50(16):4935-40. PubMed ID: 2379158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose response explorer: an integrated open-source tool for exploring and modelling radiotherapy dose-volume outcome relationships.
    El Naqa I; Suneja G; Lindsay PE; Hope AJ; Alaly JR; Vicic M; Bradley JD; Apte A; Deasy JO
    Phys Med Biol; 2006 Nov; 51(22):5719-35. PubMed ID: 17068361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunotherapy of patients with cutaneous T-cell lymphoma using an iodine-131-labeled monoclonal antibody: analysis of retreatment following plasmapheresis.
    Zimmer AM; Rosen ST; Spies SM; Goldman-Leikin R; Kazikiewicz JM; Silverstein EA; Kaplan EH
    J Nucl Med; 1988 Feb; 29(2):174-80. PubMed ID: 3258022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
    DeNardo GL; Kukis DL; Shen S; DeNardo DA; Meares CF; DeNardo SJ
    Clin Cancer Res; 1999 Mar; 5(3):533-41. PubMed ID: 10100704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a SPECT-based three-dimensional treatment planning system for radioimmunotherapy.
    Giap HB; Macey DJ; Podoloff DA
    J Nucl Med; 1995 Oct; 36(10):1885-94. PubMed ID: 7562060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deflections in computed dose distribution of I-125 seed implant due to angularly averaged approximation.
    Toivola H
    Strahlenther Onkol; 1989 May; 165(5):396-400. PubMed ID: 2727894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X-ray volumetric imaging in paediatric radiotherapy--a case study.
    McCarthy C; Davies J; Stratford J; Duffy M; Gattamaneni HR
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):194-6. PubMed ID: 17359906
    [No Abstract]   [Full Text] [Related]  

  • 20. A radionuclide therapy treatment planning and dose estimation system.
    Liu A; Williams LE; Lopatin G; Yamauchi DM; Wong JY; Raubitschek AA
    J Nucl Med; 1999 Jul; 40(7):1151-3. PubMed ID: 10405136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.